Clinical implication in the use of the AAA algorithm versus the AXB in nasopharyngeal carcinomas by comparison of TCP and NTCP values.

Radiation Oncology
Antonella BufacchiMattia Polsoni

Abstract

Retrospective analysis of volumetric modulated arc therapy treatment plans to investigate qualitative, possible, clinical consequences of the use of AAA versus AXB in nasopharyngeal cancer (NPC) cases. The dose distribution of 26 treatment plans, produced using RapidArc technique and AAA algorithm, were recalculated using AXB and the same number of monitor units provided by AAA and clinically delivered to each patient. The potential clinical effect of dosimetric differences in the planning target volume (PTV) and in organs at risk (OAR) were evaluated by comparing TCP and NTCP values. The Wilcoxon Signed Rank test was used for statistical comparison of all results obtained from the use of the two algorithms. The poorer coverage of the PTV, with higher prescribed dose, was reflected in the TCP, which was significantly lower when AXB was used, the median value was 81.55% (range: 74.90, 88.60%) and 84.10% (range: 77.70, 89.90%) for AAA (p < 0.001). OAR mean dose was lower in the AXB recalculated plan than the AAA plan and the difference was statistically significant for all the structures. The NTCP for developing mandible necrosis showed the largest median percentage difference between AAA and AXB (56.6%), the NTCP of risk for lar...Continue Reading

References

May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·B EmamiM Wesson
May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·C BurmanM Goitein
Mar 1, 1991·International Journal of Cell Cloning·F Baker, L Sanger
Jun 1, 1989·International Journal of Radiation Oncology, Biology, Physics·G J Kutcher, C Burman
May 8, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·T E WheldonA Barrett
Jul 21, 2000·Medical Physics·M R ArnfieldR Mohan
Nov 5, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Katrien De JaegerJoos V Lebesque
Mar 1, 2006·International Journal of Radiation Oncology, Biology, Physics·Issam El NaqaJoseph O Deasy
Dec 13, 2006·Medical Physics·Ann Van EschDominique P Huyskens
Jun 28, 2008·Physics in Medicine and Biology·L TillikainenW Ulmer
Mar 31, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Antonella BufacchiLuisa Begnozzi
Sep 15, 2009·International Journal of Radiation Oncology, Biology, Physics·Tiziana RancatiGiuseppe Sanguineti
Jan 9, 2010·Physics in Medicine and Biology·Oleg N VassilievFiras Mourtada
Mar 5, 2010·International Journal of Radiation Oncology, Biology, Physics·John P KirkpatrickTimothy E Schultheiss
Jul 21, 2011·Radiation Oncology·Antonella FogliataLuca Cozzi
Sep 13, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Miranda E M C ChristianenJohannes A Langendijk
Feb 4, 2012·International Journal of Radiation Oncology, Biology, Physics·Antonella FogliataLuca Cozzi
Sep 11, 2014·Journal of Applied Clinical Medical Physics·Saskia PetillionFrank Van den Heuvel

❮ Previous
Next ❯

Software Mentioned

Acuros
Eclipse

Related Concepts

Related Feeds

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.